Results 101 to 110 of about 2,889 (186)

A review of scoring instruments for the assessment of disease severity in epidermolysis bullosa acquisita

Dermatologica Sinica
Epidermolysis bullosa acquisita (EBA) is a rare, chronic autoimmune blistering disease (AIBD) characterized by mucocutaneous blistering. Typically acquired in adulthood, EBA manifests in a diverse array of clinical variants and significantly impacts ...
Aalia Syed, Sera Sarsam, Brice Serquina, Dédée F. Murrell   +3 more
doaj   +1 more source

C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita. [PDF]

Front Immunol, 2023
Guerrero-Juarez CF, Schilf P, Li J, Zappia MP, Bao L, Patel PM, Gieseler-Tillmann J, Murthy S, Cole C, Sverdlov M, Frolov MV, Hashimoto T, Ishii N, Rülicke T, Bieber K, Ludwig RJ, Sadik CD, Amber KT.   +17 more
europepmc   +1 more source

Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review. [PDF]

Front Immunol, 2023
Szymański K, Kowalewski C, Pietrzyk E, Woźniak K.   +3 more
europepmc   +1 more source

A rare clinical presentation of dermatitis herpetiformis with blisters principally on elbows: a report of three female cases

Przegląd Dermatologiczny
According to our experience, dermatitis herpetiformis usually occurs in young males who present with an itchy polymorphic eruption, without blisters or even overt vesicles, localized symmetrically on elbows, 1/3 of the proximal part of extensor surfaces ...
Magdalena Jałowska, Bogusz Falkowski, Maciej Spałek, Michał Owczarek, Justyna Gornowicz-Porowska, Monika Bowszyc-Dmochowska, Maria Raptis-Bolwach, Marian Dmochowski   +7 more
doaj   +1 more source

Refractory Epidermolysis Bullosa Acquisita with Chronic Graft-versus-Host Disease Successfully Treated with Rituximab. [PDF]

Ann Dermatol, 2023
Han JH, Yook HJ, Bang CH, Lee JH, Park YM, Lee JY.   +5 more
europepmc   +1 more source

Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients. [PDF]

Front Immunol, 2022
Kridin K, Vorobyev A, Papara C, De Luca DA, Bieber K, Ludwig RJ.   +5 more
europepmc   +1 more source

Epidermolysis bullosa acquisita treated with rituximab. [PDF]

BMJ Case Rep, 2021
Mendes SR, Coutinho I, Cardoso JC.
europepmc   +1 more source

Negatives bullöses Pemphigoid [PDF]

, 2016
Ali, H, Cozzio, A, Guenova, Emmanuella, Rinderknecht, J   +3 more
core   +1 more source

The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita. [PDF]

Front Immunol, 2023
Seiler DL, Kähler KH, Kleingarn M, Sadik CD, Bieber K, Köhl J, Ludwig RJ, Karsten CM.   +7 more
europepmc   +1 more source

Brunsting-Perry Pemphigoid of the Scalp with Antibodies against Laminin 332 [PDF]

, 2011
A. Niedermeier, Bekou V, Bruch-Gerharz D, Brunsting LA, Chan LS, Choi GS, Daito J, H. Jedlickova, Joly P, Kurzhals G, Lazarova Z, M. Hertl, Monihan JM, Murata Y, Poon E, S. Zgažarová, Tasanen K   +16 more
core   +1 more source